论文部分内容阅读
目的分析氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效。方法选择2015年1月~3月我院收治的高血压合并冠心病患者60例作为研对象,随机分为观察组和对照组,各30例,观察组给予氨氯地平阿托伐他汀钙片治疗,对照组给予阿托伐他汀钙片治疗,比较两组患者的疗效。结果观察组血压控制显效率为60.0%,显著高于对照组的23.3%,总有效率也显著高于对照组,差异有统计学意义(P<0.01);观察组总有效率为96.7%,对照组为73.3%,差异有统计学意义(P<0.05)。观察组冠心病控制情况,显效率为86.7%,对照组为46.7%,两组比较,差异有统计学意义(P<0.05);总有效率组间比较,差异无统计学意义(P>0.05)。结论高血压合并冠心病采用氨氯地平阿托伐他汀钙片治疗血压控制满意,并能够改善冠心病心电图改变。
Objective To analyze the therapeutic effect of amlodipine atorvastatin calcium on patients with hypertension and coronary heart disease. Methods Sixty patients with hypertension and coronary heart disease treated in our hospital from January to March of 2015 were randomly divided into observation group and control group, with 30 cases in each. The observation group was given amlodipine atorvastatin calcium tablets The patients in the control group were given atorvastatin calcium tablets, and the efficacy of the two groups was compared. Results The effective rate of blood pressure control in the observation group was 60.0%, significantly higher than that of the control group (23.3%), and the total effective rate was significantly higher than that of the control group (P <0.01). The total effective rate in the observation group was 96.7% The control group was 73.3%, the difference was statistically significant (P <0.05). The observation group of coronary heart disease control, markedly effective rate was 86.7%, 46.7% in the control group, the difference between the two groups was statistically significant (P <0.05); total effective rate was no significant difference between the two groups (P> 0.05 ). Conclusions Atenolol in the treatment of hypertension complicated with coronary heart disease is satisfied with the control of blood pressure and can improve the ECG changes of coronary heart disease.